CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicans

Shuichi Ito1, Joao Pedras-Vasconcelos, Dennis M Klinman

  • 1Section of Retroviral Immunology, CBER/FDA, Bethesda, MD 20892, USA.

Infection and Immunity
|August 23, 2005
PubMed

Insights

Synthetic oligodeoxynucleotides with CpG motifs usually boost immunity but unexpectedly decreased resistance to Candida albicans infection in mice. This immune response, driven by interleukin-12, highlights potential adverse effects of CpG-induced cytokine production.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Synthetic oligodeoxynucleotides (CpG) are known to stimulate innate immunity, enhancing host resistance against pathogens.
  • However, the precise impact of CpG stimulation on specific infections and the underlying mechanisms require further elucidation.

Purpose of the Study:

  • To investigate the effect of CpG treatment on host resistance to Candida albicans infection.
  • To determine the role of CpG-induced cytokines, specifically interleukin-12, in mediating these effects.

Main Methods:

  • Mice were treated with synthetic oligodeoxynucleotides containing CpG motifs.
  • Host resistance to Candida albicans infection was assessed post-treatment.
  • Interleukin-12 levels were measured to understand its involvement.

Main Results:

  • CpG treatment significantly reduced the resistance of normal mice to Candida albicans infection.
  • The observed reduction in host resistance was found to be mediated by CpG-induced interleukin-12 (IL-12).

Conclusions:

  • CpG-induced cytokine production, particularly IL-12, can have detrimental effects on host defense mechanisms.
  • These findings suggest that while CpG motifs can enhance immunity, their application requires careful consideration due to potentially adverse outcomes in certain infections.